$18.06
0.261.46%
At close: Feb 11, 4:00 PM EST
$18.06
N/A
After Hours: 4:00 PM EST
Comments
Loading...
Aktis Oncology Inc Earnings Estimates
AKTSNASDAQ
Aktis Oncology Earnings Estimates, EPS & Revenue | NASDAQ:AKTS
In the most recent quarter (Q1), Aktis Oncology reported EPS of $-0.04, beating estimates of $-0.11 by 0.64%. Revenue came in at $9.03M, exceeding the estimate of $7.32M by 0.23%.
Over the last 4 quarters, Aktis Oncology has averaged an EPS surprise of 2.81% and a revenue surprise of 0.16%.
Earnings Date
Nov 14
EPS
$-0.040
Quarterly Revenue
$9.03M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$5.56M
Aktis Oncology Earnings History
Analyze the earnings history of Aktis Oncology using advanced sorting and filters.
Aktis Oncology (AKTS) Earnings Per Share
The chart below shows Aktis Oncology's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-11-14 | $-0.04 | $-0.11 | 63.6 % |
| Q4 | 2024-10-08 | $-1.14 | $-0.10 | -1040.0 % |
| Q3 | 2024-05-13 | $-0.14 | $-0.12 | -16.7 % |
| Q2 | 2024-02-13 | $-0.19 | $-0.18 | -5.56 % |
Aktis Oncology (AKTS) Revenue
The chart below shows Aktis Oncology's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-11-14 | $9.03M | $7.32M | 23.3 % |
| Q4 | 2024-10-08 | $5.86M | $8.03M | -27.1 % |
| Q3 | 2024-05-13 | $7.51M | $8.55M | -12.2 % |
| Q2 | 2024-02-13 | $7.02M | $6.99M | 0.39 % |
FAQ
When is Aktis Oncology (NASDAQ:AKTS) reporting earnings?
Aktis Oncology (AKTS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Aktis Oncology (NASDAQ:AKTS)?
Aktis Oncology (AKTS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q1 and the Actual EPS was $-0.04, which beat the estimate of $-0.11.
What were Aktis Oncology’s (NASDAQ:AKTS) revenues?
Aktis Oncology (AKTS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q1 and the Actual Revenue was $9.03M, which beat the estimate of $7.32M.
